Please check with your insurance provider for more information, and for their most up-to-date list of panel doctors.
^Specialists may qualify to be on the Extended Panel (EP). You may enjoy selected panel benefits depending on your policy and riders.
Dr Lincoln Tan is a urologist at Gleneagles Hospital, Singapore.
His special interests are in laparoscopic and robotic-assisted surgery for the minimally invasive treatment of prostate, kidney and bladder cancers, as well as holistic care of men with prostate cancer.
Dr Tan was the former director of urologic oncology at the National University Hospital (NUH) and the National University Cancer Institute, Singapore. He is the current chairman of the Singapore Cancer Society’s prostate cancer survivorship programmes advisory committee, and a visiting consultant at NUH.
Dr Tan completed his basic training at the National University of Singapore (NUS) as well as his master's in surgery. He is a member of the Royal College of Surgeons, Edinburgh, fellow of the Royal College of Physicians and Surgeons of Glasgow in urology, and fellow of the Academy of Medicine in urology. He completed his advanced specialist urology training at NUH, and was awarded the College of Surgeons gold medal from the Academy of Medicine for being the top advanced urological trainee in his cohort. He completed his fellowship in urologic oncology and laparoscopic and tele-robotic urologic surgery at The Royal Melbourne Hospital.
He is an examiner of medical undergraduates and urological trainees, and a faculty of the Asian Urological Surgery Training & Education Group, a group of regional urologists who are passionate in sharing training opportunities in endourology and minimally invasive urological surgery to trainees in Asia. He was an assistant professor in the department of surgery at NUS Yong Loo Lin School of Medicine.
Dr Tan has a keen interest in advanced prostate cancer diagnostics to reduce unnecessary prostate biopsies, and the performance of safer, more accurate prostate biopsies. He was the principal investigator in the first local study to validate the use of the Prostate Health Index to better risk stratify men at risk of prostate cancer, to reduce subjecting men to unnecessary biopsies. He was also one of the clinical leads that introduced transperineal free-hand prostate biopsy in Singapore. He was also the earliest urologist to perform office transperineal MRI-ultrasound fusion targeted prostate biopsy.
He gives talks on prostate cancer care in Indonesia, Malaysia, China, Taiwan, Philippines and Nepal. He is a recipient of the Excellent Service Award (Silver) and the Dean’s Award for Teaching Excellence.